Alzheimer’s Drug May Benefit Some Patients, New Data Shows

The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.

Leave a Reply

Your email address will not be published. Required fields are marked *

Verified by MonsterInsights